STAAR SURGICAL CO
Extracted from this filing and checked against the source text.
STAAR SURGICAL CO shareholders approved To elect seven directors to serve for a term of office expiring at the Company’s 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified.
Proposal 1: To elect seven directors to serve for a term of office expiring at the Company’s 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Number of Shares For Withheld Broker Non-Votes Neal C. Bradsher 40,776,719 497,602 2,406,114 Arthur C. Butcher 40,565,567 708,754 2,406,114 Wei Jiang 41,098,173 176,148 2,406,114 Richard T. LeBuhn 41,170,957 103,364 2,406,114 Louis E. Silverman 40,487,195 787,126 2,406,114 Christopher M. Wang 40,941,468 332,853 2,406,114 Lilian Y. Zhou 40,488,276 786,045 2,406,114View on SEC.gov
STAAR SURGICAL CO shareholders approved To ratify the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending January 1, 2027 at the 2027-01-01 meeting.
Proposal 3 : To ratify the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending January 1, 2027: Number of Shares For Against Abstain Broker Non-Votes 43,433,234 237,151 10,050 0View on SEC.gov
STAAR SURGICAL CO shareholders approved To approve Amendment No. 2 to the Company’s Amended and Restated Omnibus Equity Incentive Plan, which increases the number of shares of Company common stock that are reserved for issuance under the plan by 3.9 million shares.
Proposal 2: To approve Amendment No. 2 to the Company’s Amended and Restated Omnibus Equity Incentive Plan, which increases the number of shares of Company common stock that are reserved for issuance under the plan by 3.9 million shares: Number of Shares For Against Abstain Broker Non-Votes 40,231,475 974,989 67,857 2,406,114View on SEC.gov
STAAR SURGICAL CO shareholders approved To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers.
Proposal 4 : To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers: Number of Shares For Against Abstain Broker Non-Votes 39,737,385 1,454,186 82,750 2,406,114View on SEC.gov
1183 shareholder votes filed in the last 30 days. Browse all shareholder votes →
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.